Related Experiment Video
Updated: Aug 17, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas
Augusto Orlandi1, Alessandro Ciucci, Amedeo Ferlosio
1Department of Anatomic Pathology, Tor Vergata University of Rome Via Montpellier 1, Rome, Italy. orlandi@uniroma2.it
Abstract:
Tumor embolism occurs in 30 to 50% of all cases of cardiac myxoma, but the causes are still uncertain. Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade the extracellular matrix (ECM) and play a crucial role in plaque instability and aortic aneurysm development, in addition to cancer and heart failure. To determine whether MMP activity contributes to tumor embolism, we examined 27 left atrium-sided myxomas, 10 of which showed clinical signs of peripheral embolism. Immunohistochemistry (in all cases) and Western blotting, and in situ and in-gel zymography (in four embolic and six nonembolic consecutive tumors) demonstrated higher expression and activity of MT1-MMP, pro-MMP-2, and pro-MMP-9 in embolic myxomas, whereas pro-MMP-1, MMP-3, and TIMP-1 levels were similar to those of nonembolic tumors. Reverse transcriptase-polymerase chain reaction demonstrated that increased MMP activity was due, at least in part, to increased transcription and that TIMP-2 transcripts increased in embolic myxomas. In vitro, embolic tumor cells retained higher MT1-MMP and pro-MMP-2 levels in basal conditions and after stimulation with interleukin-1beta and interleukin-6. Increased MMP synthesis and release correlated with enhanced ECM degradation products containing glycosaminoglycan chains in embolic myxoma tissue. Our results strongly suggest that MMP overexpression may contribute to an excessive degradation of tumor ECM and increase the risk of embolism in cardiac myxomas.
Insights
Matrix metalloproteinases (MMPs) contribute to cardiac myxoma tumor embolism by degrading extracellular matrix. Overexpression of specific MMPs in embolic myxomas suggests a key role in this process.
Area of Science:
- Cardiovascular Pathology
- Molecular Biology
- Oncology
Background:
- Tumor embolism is a frequent complication of cardiac myxoma, yet its underlying mechanisms remain unclear.
- Matrix metalloproteinases (MMPs) are implicated in matrix degradation and tissue remodeling, relevant to various pathologies including cancer and cardiovascular diseases.
Purpose of the Study:
- To investigate the role of MMPs in tumor embolism associated with cardiac myxomas.
- To determine if MMP expression and activity are elevated in myxomas prone to embolism.
Main Methods:
- Analysis of 27 left atrium-sided myxomas (10 embolic, 17 non-embolic) using immunohistochemistry, Western blotting, and zymography.
- Reverse transcriptase-polymerase chain reaction (RT-PCR) to assess MMP and TIMP gene expression.
- In vitro studies on embolic tumor cells stimulated with cytokines.
Main Results:
- Embolic myxomas exhibited higher expression and activity of MT1-MMP, pro-MMP-2, and pro-MMP-9 compared to non-embolic tumors.
- Increased MMP activity was linked to enhanced gene transcription and elevated TIMP-2 transcripts in embolic myxomas.
- Embolic tumor cells showed higher basal and cytokine-stimulated MT1-MMP and pro-MMP-2 levels, correlating with increased extracellular matrix degradation.
Conclusions:
- Matrix metalloproteinase (MMP) overexpression is strongly associated with increased extracellular matrix degradation in cardiac myxomas.
- Elevated MMP activity likely contributes to an increased risk of tumor embolism in cardiac myxoma patients.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Myocarditis I: Introduction
The Tumor Microenvironment
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
The Extracellular Matrix
Overview of Cell-Matrix Interactions
